|Day Low/High||2.52 / 2.68|
|52 Wk Low/High||2.50 / 18.90|
Pivotal Randomized Trial in 1st-line MDS Patients will Assess Overall Response Rate as Approval Endpoint
These under-$10 stocks are within range of triggering breakout trades.
Here's a technical look at how to trade several under-$10 stocks that were making big moves to the upside recently.
Global Phase 3 INSPIRE Trial of Rigosertib in Higher-Risk Myelodysplastic Syndromes Now Active in More than 90 Sites
Interim Data from Fully-Enrolled Phase 2 Trial
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Presentation highlighted during discussion session
Company Outlines Key Objectives for 2016
More than 10 European and U.S. Sites Activated
Rights to Commercialize Rigosertib in Europe to Revert to Onconova